The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of ceralasertib (AZD6738), in combination with durvalumab in patients with metastatic melanoma who have failed prior anti-PD-1 therapy.
 
Minsuk Kwon
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Simon Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Claire Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Lilly
Consulting or Advisory Role - iOnctura
 
Peter G. Mortimer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Bienvenu LoembE
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca
 
Iwanka Kozarewa
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Emma Dean
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca (I); AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca
 
Jeeyun Lee
Consulting or Advisory Role - Mirati Therapeutics; Oncologie
Research Funding - AstraZeneca; Lilly; Merck Sharp & Dohme